2014-04-02 20:51:02 - Denmark Pharmaceuticals and Healthcare Report Q1 2014 - a new market research report on companiesandmarkets.com
Pricing regulations in Denmark reflect the broader trend being felt across the European region.
However, analysts believe Denmark´s expanding and ageing population will be a significant factor, ensuring that demand for healthcare remains high. The government will inevitably need to adopt strategies and cost efficiencies to address increasing healthcare costs.
Headline Expenditure Projections:
- Pharmaceuticals: DKK20.48bn (US$3.54bn) in 2012 to DKK20.20bn (US$3.61bn) in 2013; -1.4% in local currency terms and 1.9% in US dollar terms. Forecast slightly down compared with Q413 due to macroeconomic effects.
- Healthcare: DKK202.99bn (US$35.06bn) in 2012 to DKK207.88bn (US$37.10bn) in 2013; +2.4% in local currency terms and +5.8% in US dollar terms. Forecast slightly down compared with Q413 due to macroeconomic effects.
Click for report details:
Browse all Healthcare and Medical Market Research Reports www.companiesandmarkets.com/Market/Healthcare-and-Medical/Market ..
Browse all Healthcare and Medical Company Profile Reports www.companiesandmarkets.com/Market/Healthcare-and-Medical/Compan ..
Browse all Latest Market Research Reports www.companiesandmarkets.com/Market/All/Market-Research?aCode=f3f ..
Companiesandmarkets.com is a leading online business information aggregator with over 300,000 market reports and company profiles available to our clients. Our extensive range of reports are sourced from the leading publishers of business information and provide clients with the widest range of information available. In terms of company profiles, Companiesandmarkets.comâs online database allows clients access to market and corporate information to over 100,000 different companies. We provide clients with a fully indexed database of information where clients can find specific market reports on their niche industry sectors of interest.